| scholarly article | Q13442814 |
| P2093 | author name string | S. R. Hamilton | |
| A. C. Tersmette | |||
| F. M. Giardiello | |||
| G. J. Offerhaus | |||
| A. J. Krush | |||
| S. V. Booker | |||
| N. C. Kelley | |||
| P2860 | cites work | Upper gastrointestinal pathology in familial adenomatous polyposis: results from a prospective study of 102 patients | Q37264430 |
| Mortality in patients with familial adenomatous polyposis | Q37886613 | ||
| Cohort study analysis with a FORTRAN computer program. | Q38520032 | ||
| The decline in gastric cancer: epidemiology of an unplanned triumph | Q39745547 | ||
| Upper gastrointestinal cancer in patients with familial adenomatous polyposis | Q42072445 | ||
| Upper gastrointestinal cancer in familial adenomatous polyposis. | Q54748381 | ||
| Natural history of gastric adenomas in patients with familial adenomatosis coli/Gardner's syndrome. | Q54753257 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | familial adenomatous polyposis | Q1369011 |
| P304 | page(s) | 1980-1982 | |
| P577 | publication date | 1992-06-01 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | The risk of upper gastrointestinal cancer in familial adenomatous polyposis | |
| P478 | volume | 102 |
| Q38809543 | A Clinicopathologic Evaluation of Incidental Fundic Gland Polyps With Dysplasia: Implications for Clinical Management |
| Q33916266 | A report of gastric fundic gland polyps. |
| Q42581022 | APC gene mutations and extraintestinal phenotype of familial adenomatous polyposis |
| Q46808359 | Ability of FDG-PET to detect all cancers in patients with familial adenomatous polyposis, and impact on clinical management |
| Q37606225 | Adenocarcinoma of the small bowel: a surgical dilemma. |
| Q73572312 | Adenoma of the common human bile duct in Gardner's syndrome may cause relapsing acute pancreatitis |
| Q35676719 | Ampullary adenoma: clinical manifestations, diagnosis, and treatment |
| Q42856433 | Are syndromic fundic gland polyps true neoplasms? |
| Q44290380 | Association of ampullary and colorectal malignancies |
| Q35595677 | Attenuated familial adenomatous polyposis presenting as ampullary adenocarcinoma |
| Q44761150 | CDKN2A germline mutations in familial pancreatic cancer |
| Q34756061 | Celiac disease and other precursors to small-bowel malignancy |
| Q47820449 | Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. |
| Q47647134 | Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia |
| Q54434319 | Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. |
| Q51650996 | Clinical characteristics of familial adenomatous polyposis and management of duodenal adenomas. |
| Q37682956 | Clinical outcomes of gastric polyps and neoplasms in patients with familial adenomatous polyposis |
| Q34756037 | Colon cancer: detection and prevention |
| Q37427889 | Colonic adenomatous polyposis syndromes: clinical management |
| Q34614882 | Colorectal cancer: epidemiology, risk factors, and health services |
| Q37382232 | Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis |
| Q49630216 | Current Management of Benign Epithelial Gastric Polyps |
| Q38264917 | Current status of endoscopic papillectomy for ampullary tumors. |
| Q26776181 | Current status of familial gastrointestinal polyposis syndromes |
| Q33618162 | Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis. |
| Q37971029 | Diagnosis and management of ampullary adenoma: The expanding role of endoscopy |
| Q34756013 | Diagnosis and management of hereditary colon cancer |
| Q93042146 | Diagnosis, risk stratification, and management of ampullary dysplasia by DNA flow cytometric analysis of paraffin-embedded tissue |
| Q37248373 | Diagnosis, surveillance, and treatment strategies for familial adenomatous polyposis: rationale and update. |
| Q90140707 | Different phenotypes of gastric fundic gland polyposis and cancer in patients with familial adenomatous polyposis depending on Helicobacter pylori infection |
| Q46822272 | Do we know all there is to know about Familial Adenomatous Polyposis? |
| Q26799039 | Duodenal adenoma surveillance in patients with familial adenomatous polyposis |
| Q62978361 | Duodenal adenomatosis in familial adenomatous polyposis |
| Q35754153 | Early gastric cancer development in a familial adenomatous polyposis patient |
| Q38291438 | Effect and mechanism of the Twist gene on invasion and metastasis of gastric carcinoma cells |
| Q26785673 | Endoscopic management of adenomatous ampullary lesions |
| Q81042552 | Endoscopic snare papillectomy for tumors of the duodenal papillae |
| Q64083738 | Epidemiology of Cancers of the Small Intestine: Trends, Risk Factors, and Prevention |
| Q37252956 | Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee) |
| Q37427872 | Extracolonic manifestations of hereditary colorectal cancer syndromes |
| Q37763583 | FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review |
| Q41955895 | FAP: another indication to treat H pylori |
| Q49186341 | Familial Adenomatous Polyposis with Multiple Helicobacter-negative Early Gastric Cancers Treated by Endoscopic Submucosal Dissection |
| Q36371610 | Familial Gastric Cancers |
| Q79339786 | Familial adenomatous polyposis |
| Q38884242 | Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate. |
| Q34578221 | Familial and inherited colorectal cancer: endoscopic screening and surveillance |
| Q70880695 | Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis |
| Q33630778 | Family history and the risk of gastric cancer |
| Q40171588 | Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer |
| Q42048642 | Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations |
| Q42152502 | Gall bladder carcinoma with ampullary carcinoma: a rare case of double malignancy |
| Q42000696 | Gastric adenomas in familial adenomatous polyposis are common, but subtle, and have a benign course |
| Q34390957 | Gastric cancer, Helicobacter pylori infection and other risk factors |
| Q36450770 | Gastric cancer: an update |
| Q28181834 | Gastric fundic gland polyps |
| Q38921987 | Gastric tumours in FAP. |
| Q37921953 | Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention |
| Q34012461 | Gastroduodenal lesions in familial adenomatous polyposis |
| Q71141100 | Gastroduodenal polyps in familial adenomatous polyposis |
| Q35105998 | Gastrointestinal Inherited Polyposis Syndromes |
| Q53652041 | Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes. |
| Q26744177 | Genetic risks and familial associations of small bowel carcinoma |
| Q33959675 | Genetics of hereditary colon cancer - a basis for prevention? |
| Q35790591 | Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas |
| Q34408177 | High pH reduces DNA damage caused by bile from patients with familial adenomatous polyposis: antacids may attenuate duodenal polyposis |
| Q34381290 | Iatrogenic pancreatitis in familial adenomatous polyposis |
| Q36283239 | Identification of significant pathways in gastric cancer based on protein-protein interaction networks and cluster analysis |
| Q35595017 | Impact of Helicobacter pylori infection and mucosal atrophy on gastric lesions in patients with familial adenomatous polyposis |
| Q34378109 | Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis |
| Q40693944 | Indications and contraindications for upper gastrointestinal endoscopy. |
| Q37427523 | Inherited colorectal cancer syndromes |
| Q81596754 | Is capsule endoscopy safe and useful for small-bowel surveillance in patients with familial adenomatous polyposis? |
| Q80302805 | Laparoscopic colectomy for cancer |
| Q34979798 | Long-term follow-up of patients with familial adenomatous polyposis undergoing pancreaticoduodenal surgery. |
| Q40833696 | Management of advanced duodenal polyposis in familial adenomatous polyposis |
| Q37472932 | Management of gastric polyps: a pathology-based guide for gastroenterologists |
| Q30426539 | Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu |
| Q57698678 | Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portug |
| Q44542434 | Management strategies for familial adenomatous polyposis |
| Q33680409 | Molecular basis of variegate porphyria: a missense mutation in the protoporphyrinogen oxidase gene |
| Q51371262 | Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis. |
| Q37994051 | Non-familial double malignancy of the colon and ampulla of Vater: a case report and review of literature |
| Q54546391 | Pancreas-preserving duodenectomy in the management of duodenal familial adenomatous polyposis. |
| Q54652396 | Pancreatico-duodenectomy for cancer and precancer in familial adenomatous polyposis. |
| Q40423628 | Phenotype and cancer risk of various polyposis syndromes |
| Q38030455 | Postoperative radiotherapy in periampullary cancers: a brief review |
| Q34725860 | Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis |
| Q35597651 | Prevention and management of duodenal polyps in familial adenomatous polyposis |
| Q36680098 | Primary duodenal carcinoma |
| Q35219163 | Progression of duodenal adenomatosis in familial adenomatous polyposis: due to ageing of subjects and advances in technology |
| Q40183672 | Prospective study of acute complication rates and associated risk factors in endoscopic therapy for duodenal adenomas |
| Q42637216 | Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22. |
| Q36743582 | Recurrent idiopathic pancreatitis in familial adenomatous polyposis: report of a case-series and review of the literature |
| Q34975833 | Review article: genetic testing and counselling for hereditary colorectal cancer |
| Q41563167 | Risk factors for the development of colorectal carcinoma and their modification |
| Q36431293 | Risk of subsequent primary cancers in patients with carcinoma of the Ampulla of Vater |
| Q71973138 | Role of upper gastrointestinal surveillance in patients with familial adenomatous polyposis |
| Q58791088 | Role of video capsule endoscopy in patients with constitutional mismatch repair deficiency (CMMRD) syndrome: report from the International CMMRD Consortium |
| Q52116654 | Safety and outcome of endoscopic snare excision of the major duodenal papilla. |
| Q35014007 | Screening for pancreatic cancer: current evidence and future directions. |
| Q77620874 | Small bowel tumors and polyposis syndromes |
| Q37769649 | Stem cells and cancer of the stomach and intestine |
| Q79755249 | Surveillance and Treatment of Periampullary and Duodenal Adenomas in Familial Adenomatous Polyposis |
| Q36602715 | Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis |
| Q54625016 | Surveillance of duodenal polyps in familial adenomatous polyposis: progress report. |
| Q41313530 | Surveillance of familial adenomatous polyposis patients after ileorectal anastomosis or ileoanal pouch anastomosis. |
| Q38940549 | Syndromic Gastric Polyps: At the Crossroads of Genetic and Environmental Cancer Predisposition |
| Q33760627 | The differential diagnosis and surveillance of hereditary gastrointestinal polyposis syndromes |
| Q34601452 | The epidemiology and pathogenesis of neoplasia in the small intestine |
| Q72951520 | The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment |
| Q74524853 | The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program |
| Q77679434 | The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract. American Society for Gastrointestinal Endoscopy |
| Q80101353 | Treatment of Hereditary Colorectal Cancer Syndromes |
| Q94093775 | UEG Week 2018 Poster Presentations |
| Q33675317 | Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms |
| Q37785235 | Upper Gastrointestinal Cancer Predisposition Syndromes |
| Q92486899 | Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management |
| Q36949335 | Upper gastrointestinal tumours in Japanese familial adenomatous polyposis patients. |
| Q71783993 | Upper intestinal surveillance in familial adenomatous polyposis |
| Q88778768 | Use of DNA flow cytometry in the diagnosis, risk stratification, and management of gastric epithelial dysplasia |
| Q33930152 | Villous tumors of the duodenum: biologic characters and clinical implications |
| Q73345295 | Villous tumors of the duodenum: reappraisal of local vs. extended resection |
| Q42316149 | What is the specific appearance and real frequency of gastric neoplasia in FAP patients? |
| Q42566173 | Wnt signaling, stem cells, and cancer of the gastrointestinal tract |
| Q47829438 | Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis. |
| Q39179451 | ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma |
| Q81084150 | [Clinical guidelines for the prevention of colorectal cancer] |
| Q40478961 | beta-catenin (CTNNB1) gene amplification: a new mechanism of protein overexpression in cancer. |
Search more.